Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19,336 | $19,454 | $19,398 | $17,619 |
| % Growth | -0.6% | 0.3% | 10.1% | – |
| Cost of Goods Sold | $14,579 | $14,529 | $14,504 | $12,846 |
| Gross Profit | $4,757 | $4,925 | $4,894 | $4,773 |
| % Margin | 24.6% | 25.3% | 25.2% | 27.1% |
| R&D Expenses | $183 | $232 | $229 | $221 |
| G&A Expenses | $2,366 | $2,388 | $2,369 | $0 |
| SG&A Expenses | $3,143 | $3,196 | $3,170 | $2,773 |
| Sales & Mktg Exp. | $777 | $808 | $801 | $0 |
| Other Operating Expenses | $38 | $127 | -$17 | -$73 |
| Operating Expenses | $3,364 | $3,556 | $3,382 | $2,921 |
| Operating Income | $1,392 | $1,369 | $1,512 | $1,852 |
| % Margin | 7.2% | 7% | 7.8% | 10.5% |
| Other Income/Exp. Net | -$335 | -$336 | -$292 | -$280 |
| Pre-Tax Income | $1,057 | $1,033 | $1,219 | $1,572 |
| Tax Expense | $316 | $301 | $325 | $353 |
| Net Income | $538 | $499 | $673 | $969 |
| % Margin | 2.8% | 2.6% | 3.5% | 5.5% |
| EPS | 0.92 | 0.85 | 0.57 | 0.83 |
| % Growth | 8.2% | 49.1% | -31.3% | – |
| EPS Diluted | 0.92 | 0.85 | 0.57 | 0.83 |
| Weighted Avg Shares Out | 588 | 587 | 1,173 | 1,172 |
| Weighted Avg Shares Out Dil | 587 | 587 | 1,173 | 1,172 |
| Supplemental Information | – | – | – | – |
| Interest Income | $72 | $88 | $68 | $73 |
| Interest Expense | $407 | $425 | $360 | $354 |
| Depreciation & Amortization | $1,742 | $1,752 | $1,838 | $1,624 |
| EBITDA | $3,206 | $3,210 | $3,418 | $3,549 |
| % Margin | 16.6% | 16.5% | 17.6% | 20.1% |